Articles > Popular publications > PR Newswire press releases > October-December 2001 > Monday, October 29

Article: King Pharmaceuticals Announces Jack Nicklaus As Spokesperson For Altace(R).

Article from:
PR Newswire
Article date:
October 29, 2001
Copyright

BRISTOL, Tenn., Oct. 29 /PRNewswire/ --

King Pharmaceuticals, Inc. (NYSE: KG) announced today that professional golfer, Jack Nicklaus, will serve as a spokesperson for King's product Altace(R) (ramipril), an angiotensin converting enzyme ("ACE") inhibitor. Altace(R) is marketed by Monarch Pharmaceuticals, Inc., a wholly-owned subsidiary of King, and Wyeth-Ayerst Laboratories in the United States and Puerto Rico pursuant to a co-promotion agreement. Wyeth is the pharmaceutical division of American Home Products Corporation (NYSE: AHP).

(Photo: http://www.newscom.com/cgi-bin/prnh/20010125/KGLOGO )

Altace(R) was first approved by the U.S. Food and ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: King, Schering air TV ads. (Industry Update).(for Altace, ...
Medical Marketing & Media;  May 1, 2002 ;     657 words ... ... using national television to promote Altace. A campaign was launched at the end of March featuring golfing great Jack Nicklaus in support of the beta blocker ... Print media also is being used. Altace is marketed by Monarch Pharmaceuticals ...

Article: King Pharmaceuticals Reports Efficacy of ALTACE(R) 20mg ...
Business Wire;  May 19, 2007 ;     700+ words ... ... its Phase III clinical trial evaluating ALTACE([R]) (ramipril) 20mg and the combination of ALTACE 20mg and hydrochlorothiazide (HCT) 25mg ... Illinois. The clinical trial data showed that ALTACE 20mg resulted in significant reductions ...

Article: King Pharmaceuticals Reports FDA Acceptance of Altace(R) ...
PR Newswire;  September 22, 2005 ;     700+ words ... ... sNDA") seeking a new indication for Altace(R) (ramipril). Specifically, King is seeking approval of an indication for Altace(R) as initial therapy in a multi ... clinical study, evaluated the efficacy of Altace(R) and two other treatment regimens ...

Article: Recently Reported ALLHAT Trial Does Not Address Benefits of ...
PR Newswire;  December 19, 2002 ;     700+ words ... ... converting enzyme ("ACE") inhibitor, Altace(R) (ramipril), was not included ... examined, in part, the effects of Altace(R) in reducing cardiovascular events ... cardiovascular events in patients taking Altace(R) reported from the HOPE trial include ...

Article: King Pharmaceuticals Reports Status of Pediatric Extension for ...
PR Newswire;  March 24, 2006 ;     700+ words ... ... Treatment of Pediatric Hypertension with Altace Trial) clinical trial submitted in support ... beyond patent expiry for the Company's Altace(R) (ramipril) product. In light ... request for additional information regarding Altace(R) that may produce health benefits ...

Article: King Pharmaceuticals Reports Agreement on Dismissal of ...
PR Newswire;  February 27, 2006 ;     700+ words ... ... had sought to market generic versions of Altace(R) (ramipril) before expiration of ... Patent and '856 Patent which relate to Altace(R) by filing an Abbreviated New Drug Application. About Altace(R) Altace(R) is marketed by Monarch ...

Article: King Pharmaceuticals Announces Completion of Patient Enrollment ...
PR Newswire;  November 3, 2003 ;     700+ words ... ... determine the safety and effectiveness of Altace(R) (ramipril), an ACE (angiotensin ... Treatment of Pediatric Hypertension with Altace Trial) is scheduled to conclude by the ... patients in a variety of therapeutic areas. Altace(R) is an important part of that portfolio ...

Article: King Pharmaceuticals Announces ALTACE(R) Tablets Launch.
Business Wire;  February 15, 2008 ;     700+ words ... ... announced today the launch of its new ALTACE([R]) Tablets (ramipril). King has received orders and initiated shipments of ALTACE([R]) Tablets to many of its customers ... Company will continue to make available ALTACE([R]) Capsules (ramipril). About ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives